Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-Myers shares drop after company says it will not seek fast-track drug approval
Bristol-Myers shares drop after company says it will not seek fast-track drug approval
Bristol-Myers shares drop after company says it will not seek fast-track drug approval
Submitted by
admin
on January 21, 2017 - 11:52am
Source:
CNBC
News Tags:
Bristol-Myers Squibb
fast track
lung cancer
Opdivo
Yervoy
Headline:
Bristol-Myers shares drop after company says it will not seek fast-track drug approval
Do Not Allow Advertisers to Use My Personal information
